AMN Healthcare plans $400M 2031 notes offering

AMN Healthcare Services, Inc. reports that its subsidiary AMN Healthcare, Inc. plans an unregistered offering of $400 million aggregate principal amount of senior unsecured notes due 2031 and has announced the pricing of these 2031 Notes.

Rhea-AI Filing Summary

AMN Healthcare Services, Inc. reports that its subsidiary AMN Healthcare, Inc. plans an unregistered offering of $400 million aggregate principal amount of senior unsecured notes due 2031 and has announced the pricing of these 2031 Notes. The company also states that the issuer has delivered a Conditional Notice of Redemption for all $500 million aggregate principal amount of its outstanding senior unsecured notes due 2027, with redemption scheduled for October 22, 2025, subject to the successful completion of the 2031 Notes offering.

Insights

Credit & capital structure analyst

AMN outlines a refinancing-style move by issuing 2031 notes and conditionally redeeming 2027 notes.

AMN Healthcare describes an unregistered issuance of $400 million senior unsecured notes due 2031, alongside a Conditional Notice of Redemption for all $500 million senior unsecured notes due 2027. The redemption is planned for October 22, 2025 and is explicitly conditioned on the successful completion of the 2031 Notes offering.

This structure reads as a potential maturity extension, swapping 2027 debt for 2031 obligations, though specific interest terms, covenants, or net cost changes are not included in the excerpt. The filing frames the 2027 notes redemption as contingent on closing the new issuance, so actual balance sheet effects depend on final execution of the 2031 transaction.

Investors can focus on whether the 2031 Notes offering successfully completes and on later disclosures of coupon rates or key terms that would clarify any change in interest expense or flexibility after the planned October 22, 2025 redemption date.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What debt transaction did AMN (AMN) announce in this 8-K?

The company announced an unregistered offering by AMN Healthcare, Inc. of $400 million aggregate principal amount of senior unsecured notes due 2031 and the pricing of these 2031 Notes.

How much of AMN (AMN) existing debt is targeted for redemption?

The issuer delivered a Conditional Notice of Redemption covering all of its outstanding senior unsecured notes due 2027, totaling $500 million aggregate principal amount.

When is the planned redemption date for AMN (AMN) 2027 notes?

The Conditional Notice of Redemption provides for redemption of the 2027 Notes on October 22, 2025, subject to conditions described in the notice.

What condition applies to AMN (AMN) redemption of the 2027 notes?

The redemption of the $500 million 2027 Notes is stated to be subject to the successful completion of the offering of the 2031 Notes.

Are AMN (AMN) new 2031 notes offered under a registration statement?

The company describes the 2031 Notes as part of an unregistered offering by AMN Healthcare, Inc., and clarifies that this disclosure does not constitute an offer to sell or solicit an offer to buy any security.

What exhibits accompany AMN (AMN) announcement of the 2031 notes?

The filing includes Exhibit 99.1 and Exhibit 99.2, which are press releases dated September 22, 2025 announcing the offering and pricing of the 2031 Notes, plus Exhibit 104 for the cover page interactive data file.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/22/2025 - 05:20 PM Learn about SEC filing dates

false 0001142750 0001142750 2025-09-22 2025-09-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): September 22, 2025

AMN HEALTHCARE SERVICES, INC.
(Exact name of registrant as specified in its charter)
Delaware	001-16753	06-1500476
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)
2999 Olympus Boulevard, Suite 500 Dallas, Texas 75019
(Address of principal executive offices) (Zip Code)
(866) 871-8519
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act  (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act  (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		AMN		NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 8.01. Other Events.

On September 22, 2025, the Company announced the unregistered offering by AMN Healthcare, Inc. (the “Issuer”) of $400 million aggregate principal amount of senior unsecured notes due 2031 (the “2031 Notes”). On September 22, 2025, the Company announced the pricing of $400 million aggregate principal amount of the 2031 Notes.

Copies of the press releases announcing the offering and pricing of the 2031 Notes are filed as Exhibit 99.1 and Exhibit 99.2 hereto, respectively, each of which is incorporated by reference herein.

In addition, on September 22, 2025, the Issuer delivered a Conditional Notice of Redemption to holders of its outstanding senior unsecured notes due 2027 (the “2027 Notes”), which provides for the redemption by the Issuer of all of the $500 million aggregate principal amount of 2027 Notes outstanding on October 22, 2025, subject to the successful completion of offering of the 2031 Notes.

This Current Report does not constitute an offer to sell or the solicitation of an offer to buy any security, nor shall it constitute an offer, solicitation or sale of any security, in any jurisdiction in which such offering, solicitation or sale would be unlawful.

Item 9.01. Financial Statements and Exhibits.

Exhibits.

EXHIBIT NO.		DESCRIPTION
99.1		Press Release, dated September 22, 2025
99.2		Press Release, dated September 22, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AMN Healthcare Services, Inc.
Date: September 22, 2025	By:	/s/ Brian Scott
	Name:	Brian Scott
	Title:	Chief Financial Officer